Previous Article | Next Article 
Infect Immun, July 1998, p. 3059-3065, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Comparison of Escherichia coli Strains Recovered from
Human Cystitis and Pyelonephritis Infections in Transurethrally
Challenged Mice
David E.
Johnson,1,2,*
C.
Virginia
Lockatell,1
Robert G.
Russell,3,4
J. Richard
Hebel,5
Michael D.
Island,1
Ann
Stapleton,6
Walter E.
Stamm,6 and
John W.
Warren1
Division of Infectious Diseases, Department of
Medicine,1
Program of Comparative
Medicine,3
Department of
Pathology,4 and
Department of
Epidemiology,5 University of Maryland School of
Medicine, and
Research Service, Department of Veterans
Affairs,2 Baltimore, Maryland 21201, and
Department of Medicine, University of Washington School of
Medicine, Seattle, Washington 981956
Received 15 January 1998/Returned for modification 20 February
1998/Accepted 1 April 1998
 |
ABSTRACT |
Urinary tract infection, most frequently caused by
Escherichia coli, is one of the most common bacterial
infections in humans. A vast amount of literature regarding the
mechanisms through which E. coli induces
pyelonephritis has accumulated. Although cystitis accounts for 95% of visits to physicians for symptoms of urinary tract infections, few in vivo studies have investigated possible differences between E. coli recovered from patients with
clinical symptoms of cystitis and that from patients with symptoms of
pyelonephritis. Epidemiological studies indicate that
cystitis-associated strains appear to differ from
pyelonephritis-associated strains in elaboration of some putative
virulence factors. With transurethrally challenged mice we studied
possible differences using three each of the most virulent pyelonephritis and cystitis E. coli strains in our
collection. The results indicate that cystitis strains
colonize the bladder more rapidly than do pyelonephritis strains, while
the rates of kidney colonization are similar. Cystitis strains colonize
the bladder in higher numbers, induce more pronounced
histologic changes in the bladder, and are more rapidly eliminated from
the mouse urinary tract than pyelonephritis strains. These results
provide evidence that cystitis strains differ from pyelonephritis
strains in this model, that this model is useful for the
study of the uropathogenicity of cystitis strains, and that it would be
unwise to use pyelonephritis strains to study putative virulence
factors important in the development of cystitis.
 |
INTRODUCTION |
Although the bladder, particularly
in women, is often exposed to bacteria and although urine generally
supports bacterial growth, the combined effects of bladder emptying by
urination and an intrinsic defense mechanism associated with bladder
epithelium assist in resisting bacterial infection of the bladder
(4, 28, 29). However, a breach of natural bladder
defense mechanisms resulting from anatomical abnormalities of the
urinary tract or, more commonly, virulence factors expressed by the
colonizing bacteria results in urinary tract infection (UTI).
Symptomatic UTI is manifest in two syndromes. One is acute
pyelonephritis clinically identified by flank pain and fever and
generally perceived as being a kidney infection. The second is
cystitis, characterized by dysuria and increased frequency and urgency
of urination, which is generally perceived to be a bladder infection
and accounts for 95% of all visits to physicians for UTIs
(7).
In the normal urinary tract, most UTIs are caused by Escherichia
coli. Studies on the uropathogenicity of E. coli have
focused primarily on the development of pyelonephritis. Epidemiologic studies have implicated adhesins, particularly P fimbriae, and other
factors, such as hemolysin, in the development of acute pyelonephritis;
some of these have been confirmed to be virulence factors by in vitro
and in vivo studies (9, 10, 18-20). Only recently have
epidemiologic studies begun to focus on cystitis, the more frequent UTI
syndrome. Although some putative virulence factors appear to be common,
as a group cystitis-associated strains differ from
pyelonephritis-associated strains. For instance, cystitis strains less
frequently possess P fimbriae than acute pyelonephritis strains
(2, 22, 28).
In this study, we tested the hypothesis that the widely used mouse
model of pyelonephritis introduced by Hagberg et al. (9) distinguishes E. coli strains causing acute pyelonephritis
from those causing acute cystitis.
 |
MATERIALS AND METHODS |
Bacterial strains.
Seven strains of E. coli
recovered from cultures of the urinary tracts of patients with clinical
symptoms of cystitis (36) and three strains from patients
with pyelonephritis (39) were studied. The following
characteristics of the bacterial strains were assessed: type 1 fimbriae, by mannose-sensitive agglutination of guinea pig erythrocytes
(26); P fimbriae, by mannose-resistant agglutination of
human type O erythrocytes (26); and cytotoxic necrotizing
factor (CNF), by dot blots with the CNF-encoding gene (11a).
All strains expressed type 1 fimbriae, hemolysin was expressed by one
of the three pyelonephritis-inducing and six of the seven cystitis-inducing strains, all three pyelonephritis strains and six of
the cystitis strains expressed P fimbriae, and six cystitis strains
expressed CNF. In preliminary studies pyelonephritis strains CPZ 005, CFT 073 (26), and CFT 325 (unpublished observation) colonized mouse bladder, kidneys, and urine in higher numbers than
other pyelonephritis strains tested.
For mouse challenge experiments E. coli strains were
cultured overnight on Trypticase soy agar (BBL, Cockeysville, Md.).
Cells were harvested into phosphate-buffered 0.9% sodium chloride, pH 7.2 (PBS;BBL), and adjusted to approximately 2 × 1010
CFU per ml by comparison to McFarland turbidity standards confirmed by
enumeration by the spread plate technique (Spiral Systems, Bethesda,
Md.).
Mouse model of urinary tract infection.
Female virus
antibody-free CBA/J/Hsd mice, weighing 22 to 24 g (Harlan Sprague
Dawley, Indianapolis, Ind.), were quarantined for 1 week after receipt
and allowed ad libitum access to tap water and Purina Lab Chow during
quarantine and throughout the experiment. For inoculation mice were
anesthetized with methoxyflurane (Metofane; Pitman-Moore, Washington
Crossing, N.J.). After cleansing of the periurethral area with
povidone-iodine solution which was removed with sterile water, a
sterile polyethylene catheter (0.28-mm inside diameter, 0.61-mm outer
diameter, and 25-mm length) was inserted into the bladder through the
urethra. An inoculum of 0.05 ml containing approximately
109 organisms was infused into the bladder through
the urethral catheter over 30 s through a tuberculin syringe
attached to an infusion pump (Harvard Apparatus, Millis, Mass.)
controlled by a timer (Dimco-Gray Co., Dayton, Ohio). The catheter was
removed immediately after challenge, and mice were returned to their
cages and cared for by the normal routine.
As described previously (27), in each experiment one mouse
was used to assess whether the inoculum refluxed into the kidney during
the challenge procedure. The inoculum, suspended in sterile India ink
(27), was infused into the bladder, as described
above. The reflux assessment mouse was sacrificed immediately after
challenge; the bladder, ureters, and kidneys were visually inspected
for evidence of India ink, and the kidneys were aseptically removed and
quantitatively cultured.
Experimental mice were sacrificed by CO2 overdose at 1, 3, 5, or 7 days after challenge. At sacrifice, the abdomen was opened aseptically by a midline incision and urine was aspirated from the
bladder with a tuberculin syringe for quantitative bacteriologic culture. After tying of the proximal end of each ureter, the bladder was washed by injecting and aspirating sterile saline. The bladder and
each kidney were removed aseptically and halved. One half of each organ
was separately homogenized in PBS by using a sterile glass grinder
(Kontes, Inc., Vineland, N.J.), and the other half was preserved in
10% neutral buffered formalin for histologic examination. Urine and
the homogenized tissue were quantitatively cultured on Trypticase soy
agar by the spread plate technique, and the mean number of CFU per
milliliter of urine or per gram of bladder or kidney was determined
after 24 h of incubation at 37°C.
Histological examination.
Each bladder and kidney was
divided longitudinally, and half the organ (including areas with gross
abnormality) was fixed overnight in 10% neutral buffered formalin.
Paraffin-embedded sections were stained with hematoxylin and eosin and
were examined by light microscopy by a pathologist blinded to the
infecting organism. The histologic criteria used for evaluation of
renal lesions included dilation of the pelvis, neutrophilic
infiltration and fibrosis of the pelvis, necrosis of tubular
epithelium, interstitial edema, interstitial infiltrates of neutrophils
and mononuclear cells in the cortex or medulla, presence of neutrophils
or mononuclear cells in collecting ducts and tubules, intraparenchymal
abscesses, interstitial fibrosis, tubular atrophy, and periglomerular
fibrosis. The location and distribution of the lesions were evaluated,
and the severity of lesions were graded with a scoring system in which +, ++, and +++ indicated mild, moderate, and severe pyelitis, respectively. The severity of pyelitis was graded based on low (+) or
moderate (++) numbers of inflammatory cells accumulated beneath the
epithelium lining the pelvic cavity and within the pelvic cavity, with
severe pyelitis (+++) indicated by moderate to large numbers of
inflammatory cell infiltrates surrounding the pelvis and extending into
the adjacent parenchyma. Focal areas of necrosis and desquamation of
the pelvic epithelium were more prominent in severe pyelitis and were
accompanied by local neutrophil infiltration and moderate to pronounced
purulent exudate in the lumen.
The urinary bladder was evaluated for abnormalities of the luminal
epithelium, inflammatory cell infiltrates, and the presence of
interstitial edema. The severity of lesions in the urinary bladder was
graded as follows: 1+, mild (infiltration of low numbers of neutrophils
in the lamina propria, little or no interstitial edema, and absence or
local evidence of regenerative hyperplasia in the luminal epithelium);
2+, moderate (infiltration of moderate numbers of neutrophils in the
lamina propria, moderate interstitial edema, and moderate generalized
hyperplasia of the luminal epithelium); and 3+, severe (diffuse
infiltration of moderate to large numbers of neutrophils in the lamina
propria, severe interstitial edema, and severe generalized hyperplasia
of the luminal epithelium).
Urinary bladders from unchallenged CBA mice were used to examine
adherence of E. coli strains to bladder mucosa by a
previously described technique (12). Mice were sacrificed by
CO2 overdose. Each urinary bladder was aseptically removed,
cut to expose the mucosal surface, and placed in a plastic jig. The jig
consisted of two polycarbonate squares (a 12-mm-thick base and a
12-mm-thick upper piece containing a 6-mm-diameter hole) held together
with a nut and bolt at each corner. The cut mouse bladder was placed into the jig with the mucosal surface up (facing the 6-mm-diameter hole). When the upper piece of the jig was secured to the base, the
bladder tissue created a watertight seal at the base of the hole. A
bacterial suspension of a washed broth culture (200 µl; 1010 CFU/ml) was placed in the 6-mm-diameter well and
allowed to remain in contact with the bladder mucosa for up to 2 h
at 37°C. The bacterial suspension was aspirated from the well, and
the bladder mucosa was washed three times with PBS (pH 7.2). Bladders
were fixed in 2.5% gluteraldehyde in 0.1 M cacodylate buffer (pH 7.4), postfixed in 1% osmium tetroxide in 0.1 M cacodylate buffer (pH 7.4),
dehydrated in ethanol and hexamethyldisilazone, gold and palladium
coated (Hummer II sputter coater), and examined by scanning electron
microscopy (JEOL model JSM T200).
Statistical analysis.
Mean numbers of CFU per milliliter or
per gram from cultures of urine or tissue homogenates and mean
histologic scores were compared by Student's t test.
Differences in the numbers of mice with bladder or kidney colonized by
the challenge organism were compared by chi-square analysis.
P values for the tests of the bladder/kidney ratios were
calculated using Wilcoxon's signed rank test. To evaluate the
association between urine or tissue counts and tissue histology scores,
product-moment correlation coefficients were determined for each day of
animal examination and then pooled.
 |
RESULTS |
Inspection of the reflux assessment mouse from each experiment
immediately after inoculation revealed that India ink was present in
each bladder but could not be visualized in the ureters or kidneys of
any mice, and the challenge organism was not recovered from culture of
kidney homogenates of any reflux assessment mouse.
Seven cystitis strains randomly selected from a total of 20 strains in
our collection were evaluated in mice to assess uropathogenicity (Fig. 1). At sacrifice 1 week after
challenge, strains f3, f11, and f54 were found to colonize the
bladder and kidney better than the other four strains. These
three strains were used in additional experiments to compare
their uropathogenicities with those of the three pyelonephritis strains
in our collection that had been found in previous screening
experiments to best colonize mouse urine, bladder, and kidneys (CFT
073, CFT 325, and CPZ 005).

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 1.
Colonization of bladder (), kidney ( ), or
urine ( ) in mice 7 days after experimental transurethral challenge
with E. coli strains originally isolated from patients with
clinical symptoms of cystitis. The challenge dose was 109
CFU per mouse. Data are means ± standard errors of the means for
five mice per E. coli strain.
|
|
The patterns of mouse UTI produced by cystitis and pyelonephritis
strains were different. These were compared by examining the mean
bacterial density and prevalence of infection (proportion of animals
with
103 CFU per ml of urine or per g of tissue) at each
time point (Fig. 2).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Colonization of mouse bladder (A), kidney (B), and urine
(C) following experimental transurethral challenge with E. coli strains originally isolated from patients with clinical
symptoms of cystitis ( ) or pyelonephritis ( ). The challenge dose
was 109 CFU per mouse. Data points (*P 0.05) are means ± standard errors of the means for 15 mice
examined per day (5 mice for each of the cystitis strains f3, f11, and
f54 and 5 mice for each of the pyelonephritis strains CFT 073, CFT 325, and CPZ 005). Numbers at each data point are numbers of mice with
103 CFU per g or per ml of specimen per the total number
of mice for which bacterial growth was detected in at least one
specimen.
|
|
With cystitis strains, most animals were infected on days 1 and 3 with
concentrations of 106 to 108 per g in the
bladder and per ml of urine and about 103 per g in the
kidney. After day 3, though most animals remained infected, the
concentrations of organisms began to fall in each site, so that by day
7 the mean concentrations were <104 per g in the bladder
and per ml of urine and <102 per g in the kidneys. In the
same experiments, the pyelonephritis strains, though infecting the
majority of animals, were initially found at concentrations of only
103 to 104 per g or tissue or per ml of urine.
However, these organisms tended to persist at these concentrations in
the kidneys and urine throughout the observation period.
A comparison of the cystitis and pyelonephritis strains is instructive.
At 1 day after challenge, there was significantly greater
colonization of the bladder (2 × 106 versus 2 × 104; P = 0.013) and urine (9 × 107 versus 2 × 104; P = 0.003) by cystitis strains than by pyelonephritis strains; the kidney
colonization results were similar (2 × 103 versus
8 × 102; P = 0.62). At 3 days after
challenge, the cystitis strains continued to colonize the bladder
(2 × 106 versus 1 × 102;
P < 0.001) and urine (107 versus
103; P = 0.001) better than the
pyelonephritis strains; they also colonized the kidney (8 × 103 versus 4 × 102; P = 0.02) better. At 5 days after challenge, cystitis strains were still
recovered from bladder homogenates in significantly higher numbers than
were pyelonephritis strains (3 × 104 versus 1 × 102; P = 0.002). But by 7 days after
challenge, due to declining colonization by cystitis strains combined
with persistent or increasing colonization by pyelonephritis strains,
recovery of cystitis strains was similar to that of pyelonephritis
strains from the bladder (3 × 103 versus 5 × 103; P = 0.83) and from the urine (2 × 103 versus 6 × 104; P = 0.67). At this time pyelonephritis strains colonized the kidney
better than did cystitis strains (2 × 103 versus
7 × 101; P = 0.03).
These findings were generally reflected in the prevalence of infection
in tissue and urine. Cystitis strains were found at a significantly
higher prevalence than pyelonephritis strains in the bladder on days 3 (15 of 15 versus 7 of 14; P < 0.002) and 5 (13 of 14 versus 7 of 14; P = 0.012) and in urine on days 1 (14 of 15 versus 9 of 14; P = 0.05) and 3 (14 of 15 versus
8 of 14; P = 0.02). Over the 7-day observation period,
cystitis strains resulted in significantly higher proportions than
pyelonephritis strains of animals with
103 CFU per g or
per ml in bladder tissue (52 of 56 versus 37 of 57; P = 0.0006) and urine (46 of 56 versus 37 of 57; P = 0.036). However, in the kidney, at no time point were cystitis strains more prevalent than pyelonephritis strains (
25 of 30 versus 18 of 28;
P
0.09); over the observation period, the
proportions of infected kidneys did not differ for cystitis and
pyelonephritis strains (74 of 112 versus 75 of 114; P = 0.92).
Figure 3 represents the ratio of bladder
to kidney bacterial concentration at the different time points. At all
time points for cystitis strains and on day 1 for pyelonephritis
strains, the ratio was significantly greater than 1 (P
0.044). For days 3, 5, and 7, the ratio for pyelonephritis strains
was not significantly different than 1 (P
0.35).
This demonstrates that cystitis strains throughout the 7-day experiment
infected bladder tissue at significantly greater concentration than
kidney tissue. Indeed, even as cystitis strains declined in bacterial
density throughout the urinary tract, they continued to infect the
bladder in higher concentrations than the kidneys. Cystitis strains
were found in the bladder on day 1 at 1,000 times the concentration in
the kidney (Fig. 2 and 3), on day 3 at about 180 times, and by days 5 and 7 at about 40 times. On the other hand, pyelonephritis strains were
found in the bladder at substantially higher concentrations than in the
kidney (24 times) (Fig. 2 and inset in Fig. 3) only on day 1. On days 3 through 7, either pyelonephritis strains were found in greater
concentration in the kidney (days 3 and 5) or the bladder concentration
was only twice the kidney concentration (day 7).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
Ratio of mean bladder CFU to mean kidney CFU for mice
challenged transurethrally with E. coli strains isolated
from patients with clinical symptoms of cystitis ( ) or
pyelonephritis ( ). The inset shows the ratios for mice challenged
with pyelonephritis strains only.
|
|
The cystitis strains caused mild to moderate cystitis which persisted
through day 7 (Fig. 4). Bladders from
mice challenged with cystitis strains had interstitial infiltrates of
large numbers of inflammatory cells, mostly neutrophils, prominent
interstitial edema, and generalized thickening of the bladder
epithelium attributed to regenerative hyperplasia (Fig.
5). On the other hand, the pyelonephritis strains elicited very minimal changes in bladder histology (Fig. 6), significantly less marked than those
elicited by cystitis strains on days 1, 3, and 7. Of the 60 mice
challenged with cystitis strains and examined over the 7-day
observation period, 56 (94%) had histologic evidence of cystitis,
compared to only 24 of 60 (40%) mice challenged with pyelonephritis
strains (P < 0.0001). Histologic changes in the
kidneys increased over the 7-day period and were greater than changes
seen in the bladder. However, unlike the changes seen in the bladder,
the histologic changes in the kidneys induced by cystitis strains and
by pyelonephritis strains on days 1, 3, and 5 were not significantly
different (P
0.12). On day 7 greater changes in
kidney histology were seen in mice challenged with cystitis strains
than in mice challenged with pyelonephritis strains (P = 0.052).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
Mean histology index scores (± standard errors of the
means) for mice (15 mice per group) that received transurethral
challenge with 109 CFU of E. coli strains
isolated from patients with clinical symptoms of cystitis ( ) or
pyelonephritis ( ).
|
|

View larger version (139K):
[in this window]
[in a new window]
|
FIG. 5.
Photomicrograph of mouse bladder showing moderate
cystitis (2+) on day 3 after infection with E. coli f11 (a
human cystitis strain). The histopathologic changes are characterized
by prominent interstitial edema (asterisk) and diffuse infiltration of
large numbers of neutrophils (arrow) in the lamina propria. The
epithelium is thickened due to regenerative hyperplasia.
|
|

View larger version (148K):
[in this window]
[in a new window]
|
FIG. 6.
Photomicrograph of mouse bladder showing mild cystitis
(1+) on day 3 after infection with E. coli CFT 073 (a human
pyelonephritis strain). The lamina propria appears normal because there
is no edema and only low numbers of neutrophils (arrow) are seen. The
epithelium exhibits only localized hyperplasia (above arrow).
|
|
Differences between cystitis and pyelonephritis strains were also
observed when mouse bladders exposed in vitro to bacterial suspensions
were examined by scanning electron microscopy. As seen in Fig.
7, after 1 h of exposure of the
bladder mucosa to E. coli suspension, cells of cystitis
strain f11 (Fig. 7A), but not of pyelonephritis strain CFT 073 (Fig.
7B), were observed adhering to the bladder mucosa. After 2 h of
exposure cells of f11 were still adhering (Fig. 7C) and no CFT 073 adherence was observed (Fig. 7D); the mucosal surface appeared to be
disrupted after f11 exposure for 2 h (Fig. 7C) but not after CFT
073 exposure (Fig. 7D). These observations appear to be consistent
with microbiologic results, which showed significantly greater
colonization of the bladder by cystitis strains, and with light
microscopic results, which showed early epithelial damage followed by
generalized regenerative hyperplasia of bladder mucosa in mice
challenged with cystitis strains but not in those challenged with
pyelonephritis strains.

View larger version (149K):
[in this window]
[in a new window]
|
FIG. 7.
Scanning electron photomicrographs of mouse bladder
mucosa after in vitro exposure to E. coli suspensions. After
1 h of exposure cells of cystitis strain f11 are observed adhering
to the bladder mucosa (A) but no cells of pyelonephritis strain CFT 073 are observed (B). After 2 h of exposure to cystitis strain f11,
the bladder mucosa appears to be disrupted (C), unlike mucosa exposed
to pyelonephritis strain CFT 073 for 2 h (D), which appears
similar to mucosa exposed to PBS (pH 7.2) for 2 h (data not
shown). Magnifications, ×2,000 (A and B) and ×500 (C and D).
|
|
Figure 8 shows the correlation
coefficients for bladder, kidney, and urine quantitative counts plotted
against bladder and histology scores. The strongest correlations were
between kidney quantitative counts and kidney histology for cystitis
strains (r = 0.36; P = 0.005) and for
pyelonephritis strains (r = 0.38; P = 0.003). For cystitis strains, but not for pyelonephritis strains, bladder histology scores were significantly correlated with bladder and
urine colony counts. For pyelonephritis strains the only significant correlation was that between kidney histology scores and kidney colony
counts.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 8.
Correlations for the relationship of bladder (b), kidney
(k), or urine (u) log10 CFU to bladder histology (BH) or
kidney histology (KH) scores for mice challenged with E. coli strains isolated from patients with clinical symptoms of
cystitis or pyelonephritis. The correlation coefficients were derived
from data for mice examined 1, 3, 5, and 7 days after transurethral
challenge. The error bars show the 95% confidence intervals for the
pooled correlation coefficients.
|
|
 |
DISCUSSION |
The majority of UTIs are caused by E. coli (34,
36). Strains that infect the urinary tract are a subset of
strains which colonize the colon and possess characteristics, or
virulence factors, which allow them to interact with host urinary cells
and induce symptomatic urinary infections (38). E. coli strains isolated from patients with clinical symptoms of
acute pyelonephritis have been studied extensively. These strains
express a number of virulence factors associated epidemiologically with
acute pyelonephritis. P fimbriae, the most extensively studied
urovirulence factor, mediate the adherence of these organisms to the
digalactoside receptor,
-D-Gal-(1
4)-
-D-Gal, the predominant
glycolipid found in human kidney tissue (18, 24, 37). The
association of P-fimbrial expression and renal infection in mice has
been confirmed (9).
A reasonable question might be whether the only distinction between
cystitis and pyelonephritis is the site where the organism happens to
attach. There are reports suggesting that this sometimes may be the
case, i.e., that apparently the same organism earlier causing acute
pyelonephritis has caused cystitis upon recurrence in the same patient
(2, 33). However, there are other data indicating that
cystitis strains as a group are different from pyelonephritis strains.
The two groups differ in distribution of O, K, and H serotypes
(33). Cystitis strains adhere less well to uroepithelial
cells, are less likely to mediate mannose-resistant hemagglutination,
and are less often P fimbriated (2, 33, 36). PapG III but
not PapG II adhesins appear to be prominent in P-fimbriated cystitis
strains (2, 36). Dr adhesins may be associated with cystitis
strains more than pyelonephritis strains, particularly in children
(2, 36). A multivariate analysis demonstrated that cystitis
strains are 40 times more likely than fecal strains to display
mannose-resistant hemagglutination not mediated by P
fimbriae, a feature not characteristic of pyelonephritogenic strains
(35). Taken together, these data suggest that many cases of
cystitis are caused by E. coli strains different from those causing acute pyelonephritis.
Although others have assessed the interaction of E. coli
strains and mouse bladder (1, 5, 8, 21) or the development of cystitis and pyelonephritis following experimental challenge of mice
or nonhuman primates with E. coli (16, 31, 32), this is the first study to assess differences between the
uropathogenicities of pyelonephritis and cystitis strains of E. coli in an animal model of UTI. We chose to use the
transurethrally challenged mouse model which was originally described
by Hagberg et al. (9), who documented that a
P-fimbria-expressing strain colonized the kidney better than
P-fimbria-negative strains. Subsequent studies have shown that the
model may be useful in assessing in vivo potential immunogens for
prevention of pyelonephritis (30) and may be adapted to
study other aspects of UTI, including Providencia stuartii (12) and Proteus mirabilis (15, 17,
25) uropathogenicity and the effects of an indwelling bladder
catheter (13) and urethral obstruction (14).
We hypothesized that the model could be used to study whether patterns
of uropathogenicity from E. coli strains isolated from patients with cystitis and from those with pyelonephritis differed. The
constraints of cost and time prevented us from comparing the uropathogenicities of all of the 71 pyelonephritis strains and the 20 cystitis strains in our collection. We chose to compare the most
virulent strains in each group as determined by separate screening studies in mice. We should note that the screening
procedures for the two groups were different. The pyelonephritis
strains were screened in mice challenged transurethrally with
1010 CFU/mouse and examined 2 days after challenge, whereas
the cystitis strains were screened in mice challenged transurethrally
with 109 CFU/mouse and examined 7 days after challenge. The
three most uropathogenic strains (greatest colonizers
of the bladder and kidney) in each group were selected for comparative
studies of mice in which the challenge dose (109 CFU/mouse)
and examination times (1, 3, 5, and 7 days after challenge) were
standardized.
In the comparative in vivo and in vitro infection studies in mice, the
cystitis strains colonized the bladder and urine significantly better
than did the pyelonephritis strains. Moreover, significantly more mice
challenged with cystitis strains had histologic evidence of
cystitis, the mean bladder histology scores were significantly higher
than they were in mice challenged with pyelonephritis strains, and, by
scanning microscopy, the bladder mucosa was observed to be disrupted
after 2 h of exposure to cystitis strains but not after
exposure to pyelonephritis strains. These observations
demonstrate that the rapid urinary tract colonization by cystitis
strains has a propensity for bladder colonization. Over the 7-day
observation period there was a significant reduction in bladder,
kidney, and urine colonization by cystitis strains, while
colonization of the urinary tract by pyelonephritis strains
persisted or increased slightly.
This model does appear to distinguish cystitis from pyelonephritis
strains. The cystitis strains infect the bladder and urine at high
concentrations for up to 3 days and then begin to clear from the
urinary tract. The pyelonephritis strains, though infecting at
initially lower concentrations, tend to persist in the bladder, kidney,
and urine, so that by the end of a 7-day observation period they
are present in higher concentrations in the kidney than are the
cystitis strains. Even as the cystitis strains are declining in
concentration throughout the urinary tract, they tend to have greater
bacterial densities in the bladder than in the kidney. On the other
hand, the pyelonephritis strains are present at higher concentrations
in the bladder first, and thereafter the kidney concentrations are
either higher than or equivalent to the bladder concentrations.
For pyelonephritis strains the only significant correlation
between bacterial count and tissue histology was that between kidney counts and kidney histology scores. This correlation may reflect
the propensity of these strains for preferentially infecting and
damaging the kidney. These results appear to be consistent with
observations by other authors who have noted a lack of correlation between urine counts and bladder or kidney counts when studying pyelonephritis strains (9, 11). In contrast, for
cystitis strains there were weak but significant correlations between
urine or bladder counts and bladder histology scores and urine and
between bladder or kidney counts and kidney histology scores. This is another example of differences between cystitis and pyelonephritis strains and suggests that for cystitis strains quantitative urine culture results may be useful in monitoring bladder and kidney infection in mice.
We believe that this model mimics in many ways the important features
of cystitis in humans. The model is of females, the inoculum is
introduced into the bladder, and bacteriuria is a concomitant part of
the infection. Cystitis strains infect the bladder in greater
concentrations than the kidney. It is interesting that while most
clinicians ascribe cystitis to an infection of the bladder, 15 to 25%
of "cystitis" cases may actually have bacteria above the level of
the bladder as well (3, 6). In our animal model cystitis
strains spontaneously began to clear from the urine and urinary tract.
While the natural history of cystitis in humans is difficult to
ascertain in the era of antibiotics, in a randomized trial Mabeck
assigned 53 nonpregnant women with symptomatic bacterial cystitis to
placebo therapy (23). Of these, eight required antibiotic therapy because of persistent symptoms. However, of the remaining 45, 43 cleared the bacteriuria without antibiotics, 32 within 1 month
(23).
The mechanisms responsible for the observed differences in urinary
tract colonization by cystitis and pyelonephritis strains are not
known. Presumably, pyelonephritis strains persist in the urinary tract
as a result of expression of adhesins that promote colonization of the
uroepithelium. Studies are ongoing to determine bacterial and host
factors which are important in the induction of cystitis by E. coli strains isolated from patients with clinical symptoms of
cystitis.
Differences between patterns of urinary tract colonization by cystitis
and pyelonephritis strains were clearly demonstrated by using the
transurethrally challenged mouse model. This suggests two important
consequences. First, the model should be useful in defining factors
that promote infection of the lower urinary tract by cystitis strains.
Secondly, since the patterns of urinary tract colonization by cystitis
and pyelonephritis strains are different, it would be unwise to attempt
to study cystitis by using bacterial strains isolated from patients
with clinical symptoms of pyelonephritis.
 |
ACKNOWLEDGMENTS |
This work was supported by Public Health Service grant 1 PO1
DK49720-01 from the National Institute of Diabetes and Digestive and
Kidney Diseases and by the Research Service, Department of Veterans
Affairs.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Research Service
(151), VA Medical Center, 10 North Greene St., Baltimore, MD
21201. Phone: (410) 605-7130. Fax: (410) 605-7906. E-mail:
dejohnso{at}umaryland.edu.
Editor: J. T. Barbieri
 |
REFERENCES |
| 1.
|
Aronson, M.,
O. Medalia,
L. Schori,
D. Mirelman,
N. Sharon, and I. Ofek.
1979.
Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl -D-mannopyranoside.
J. Infect. Dis.
139:329-332[Medline].
|
| 2.
|
Arthur, M.,
C. E. Johnson,
R. H. Rubin,
R. D. Arbeit,
C. Campanelli,
C. Kim,
S. Steinbach,
M. Agarwal,
R. Wilkinson, and R. Goldstein.
1989.
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli.
Infect. Immun.
57:303-313[Abstract/Free Full Text].
|
| 3.
|
Busch, R., and J. Huland.
1984.
Correlation of symptoms and results of direct bacterial localization in patients with urinary tract infections.
J. Urol.
132:282-285[Medline].
|
| 4.
|
Cox, C. E., and F. Hinman.
1961.
Experiments with induced bacteriuria, vesical emptying and bacterial growth on the mechanism of bladder defense to infection.
J. Urol.
86:739-748[Medline].
|
| 5.
|
Dalal, E.,
O. Medalia,
O. Harari, and M. Aronson.
1994.
Moderate stress protects female mice against bacterial infection of the bladder by eliciting uroepithelial shedding.
Infect. Immun.
62:5505-5510[Abstract/Free Full Text].
|
| 6.
|
Eykyn, S.,
R. W. Lloyd-Davies,
K. E. Shuttleworth, and J. Vinnicombe.
1972.
The localization of urinary tract infection by ureteric catheterization.
Investig. Urol.
9:271-275[Medline].
|
| 7.
|
Ferry, S.,
L. G. Burman, and S. E. Holm.
1988.
Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing.
Scand. J. Infect. Dis.
20:535-544[Medline].
|
| 8.
|
Gillon, G.,
M. Small,
O. Medalia, and M. Aronson.
1984.
Sequential study of bacterial clearance in experimental cystitis.
J. Med. Microbiol.
18:319-326[Abstract].
|
| 9.
|
Hagberg, L.,
I. Engberg,
R. Freter,
J. Lam,
S. Olling, and C. Svanborg Edén.
1983.
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
Infect. Immun.
40:273-283[Abstract/Free Full Text].
|
| 10.
|
Hull, R. A.,
R. E. Gill,
P. Hsu,
B. H. Minshew, and S. Falkow.
1981.
Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.
Infect. Immun.
33:933-938[Abstract/Free Full Text].
|
| 11.
|
Hultgren, S. J.,
T. N. Porter,
A. J. Schaeffer, and J. L. Duncan.
1985.
Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.
Infect. Immun.
50:370-377[Abstract/Free Full Text].
|
| 11a.
| Island, M. D. Personal communication.
|
| 12.
|
Johnson, D. E.,
C. V. Lockatell,
M. Hall-Craggs,
H. L. T. Mobley, and J. W. Warren.
1987.
Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients.
J. Urol.
138:632-635[Medline].
|
| 13.
|
Johnson, D. E.,
C. V. Lockatell,
M. Hall-Craggs, and J. W. Warren.
1991.
Mouse models of short- and long-term foreign body in the urinary bladder: analogies to the bladder segment of urinary catheters.
Lab. Anim. Sci.
41:451-455[Medline].
|
| 14.
|
Johnson, D. E.,
R. G. Russell,
C. V. Lockatell,
J. C. Zulty, and J. W. Warren.
1993.
Urethral obstruction of 6 hours or less causes bacteriuria, bacteremia, and pyelonephritis in mice challenged with "nonuropathogenic" Escherichia coli.
Infect. Immun.
61:3422-3428[Abstract/Free Full Text].
|
| 15.
|
Johnson, D. E.,
R. G. Russell,
C. V. Lockatell,
J. C. Zulty,
J. W. Warren, and H. L. T. Mobley.
1993.
Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
Infect. Immun.
61:2748-2754[Abstract/Free Full Text].
|
| 16.
|
Johnson, J. R.,
T. Berggren,
D. S. Newburg,
R. H. McCluer, and J. C. Manivel.
1992.
Detailed histopathological examination contributes to the assessment of Escherichia coli urovirulence.
J. Urol.
147:1160-1166[Medline].
|
| 17.
|
Jones, B. D.,
C. V. Lockatell,
D. E. Johnson,
J. W. Warren, and H. L. T. Mobley.
1990.
Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection.
Infect. Immun.
58:1120-1123[Abstract/Free Full Text].
|
| 18.
|
Kallenius, G., and R. Molby.
1979.
Adhesion of Escherichia coli to human periurethral cells correlated to mannose-resistant agglutination of human erythrocytes.
FEMS Microbiol. Lett.
5:295-299.
|
| 19.
|
Kallenius, G.,
S. B. Svenson,
R. Molby,
B. Cedergren,
H. Hultberg, and J. Winberg.
1981.
Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli.
Lancet
ii:604-606.
|
| 20.
|
Korhonen, T. K.,
S. Eden, and C. Svanborg-Eden.
1980.
Binding of purified Escherichia coli pili to human urinary tract epithelial cells.
FEMS Microbiol. Lett.
7:237-240.
|
| 21.
|
Liao, J.,
K. Tomochika,
S. Watanabe, and Y. Kanemasa.
1992.
Establishment of a mouse model of cystitis and roles of type 1 fimbriated Escherichia coli in its pathogenesis.
Microbiol. Immunol.
36:243-256[Medline].
|
| 22.
|
Lindstedt, R.,
G. Larson,
P. Falk,
U. Jodal,
H. Leffler, and C. Svanborg.
1991.
The receptor repertoire defines the host range for attaching Escherichia coli strains that recognize globo-A.
Infect. Immun.
59:1086-1092[Abstract/Free Full Text].
|
| 23.
|
Mabeck, C. E.
1972.
Treatment of uncomplicated urinary tract infection in non-pregnant women.
Postgrad. Med. J.
48:69-75[Medline].
|
| 24.
|
Marcus, D. M., and R. Janis.
1970.
Localization of glycosphingolipids in human tissues by immunofluorescence.
J. Immunol.
104:1530-1539[Abstract/Free Full Text].
|
| 25.
|
Massad, G.,
C. V. Lockatell,
D. E. Johnson, and H. L. T. Mobley.
1994.
Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection.
Infect. Immun.
62:536-542[Abstract/Free Full Text].
|
| 26.
|
Mobley, H. L. T.,
D. M. Green,
A. L. Trifillis,
D. E. Johnson,
G. R. Chippendale,
C. V. Lockatell,
B. D. Jones, and J. W. Warren.
1990.
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.
Infect. Immun.
58:1281-1289[Abstract/Free Full Text].
|
| 27.
|
Mobley, H. L. T.,
K. G. Jarvis,
J. P. Elwood,
D. I. Whittle,
C. V. Lockatell,
R. G. Russell,
D. E. Johnson,
M. S. Donnenberg, and J. W. Warren.
1993.
Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of Gal(1-4) Gal binding in virulence of a wild-type strain.
Mol. Microbiol.
10:143-155[Medline].
|
| 28.
|
Norden, C. W.,
G. M. Green, and E. H. Kass.
1968.
Antibacterial mechanisms of the urinary bladder.
J. Clin. Invest.
47:2689-2700.
|
| 29.
|
O'Grady, F., and W. R. Cattell.
1966.
Kinetics of urinary tract infection. II. The bladder.
Br. J. Urol.
38:156-162[Medline].
|
| 30.
|
O'Hanley, P.,
D. Lark,
S. Falkow, and G. Schoolnik.
1985.
Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice.
J. Clin. Invest.
75:347-359.
|
| 31.
|
Roberts, J. A.,
M. B. Kaak, and E. N. Fussell.
1989.
Bacterial adherence in urinary tract infections: preliminary studies in a primate model.
Infection
17:401-404[Medline].
|
| 32.
|
Roberts, R. A.,
G. M. Surarez,
B. Kaack,
G. Kallenius, and S. B. Svenson.
1985.
Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux.
J. Urol.
133:1068-1075[Medline].
|
| 33.
|
Sandberg, T.,
B. Kaijser,
G. Lidin-Janson,
K. Lincoln,
F. Ørskov,
I. Ørskov,
E. Stokland, and C. Svanborg-Edén.
1988.
Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection.
J. Clin. Microbiol.
26:1471-1476[Abstract/Free Full Text].
|
| 34.
|
Savage, D. C. L.,
G. Howie,
K. Adler, and M. I. Wilson.
1975.
Controlled trial of therapy in covert bacteriuria of childhood.
Lancet
i:358-361.
|
| 35.
|
Siitonen, A.,
R. Martikainen,
R. Ikaheimo,
J. Palmgren, and P. H. Makela.
1993.
Virulence-associated characteristics of Escherichia coli in urinary tract infection: a statistical analysis with special attention to type 1C fimbriation.
Microb. Pathog.
15:65-75[Medline].
|
| 36.
|
Stapleton, A.,
S. Moseley, and W. E. Stamm.
1991.
Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women.
J. Infect. Dis.
163:773-779[Medline].
|
| 37.
|
Svanborg-Eden, C.,
L. A. Hanson,
U. Jodal,
U. Lindberg, and A. S. Akerlund.
1976.
Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection.
Lancet
ii:490-492.
|
| 38.
|
Warren, J. W.
1997.
Host-parasite interactions and host defense mechanisms, p. 873-893.
In
R. W. Schrier, and C. W. Gottschalk (ed.), Diseases of the kidney, 6th ed., vol. 1. Little, Brown and Company, Boston, Mass.
|
| 39.
|
Warren, J. W.,
E. H. Miller, Jr.,
B. Fitzpatrick,
D. E. DiFranco,
E. S. Caplan,
J. H. Tenney, and W. C. Anthony.
1983.
A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli.
Rev. Infect. Dis.
5:S173-S180.
|
Infect Immun, July 1998, p. 3059-3065, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nielubowicz, G. R., Smith, S. N., Mobley, H. L. T.
(2008). Outer Membrane Antigens of the Uropathogen Proteus mirabilis Recognized by the Humoral Response during Experimental Murine Urinary Tract Infection. Infect. Immun.
76: 4222-4231
[Abstract]
[Full Text]
-
Jacobsen, S. M., Stickler, D. J., Mobley, H. L. T., Shirtliff, M. E.
(2008). Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev.
21: 26-59
[Abstract]
[Full Text]
-
Hagan, E. C., Mobley, H. L. T.
(2007). Uropathogenic Escherichia coli Outer Membrane Antigens Expressed during Urinary Tract Infection. Infect. Immun.
75: 3941-3949
[Abstract]
[Full Text]
-
Bryan, A., Roesch, P., Davis, L., Moritz, R., Pellett, S., Welch, R. A.
(2006). Regulation of Type 1 Fimbriae by Unlinked FimB- and FimE-Like Recombinases in Uropathogenic Escherichia coli Strain CFT073. Infect. Immun.
74: 1072-1083
[Abstract]
[Full Text]
-
Snyder, J. A., Lloyd, A. L., Lockatell, C. V., Johnson, D. E., Mobley, H. L. T.
(2006). Role of Phase Variation of Type 1 Fimbriae in a Uropathogenic Escherichia coli Cystitis Isolate during Urinary Tract Infection. Infect. Immun.
74: 1387-1393
[Abstract]
[Full Text]
-
Snyder, J. A., Haugen, B. J., Lockatell, C. V., Maroncle, N., Hagan, E. C., Johnson, D. E., Welch, R. A., Mobley, H. L. T.
(2005). Coordinate Expression of Fimbriae in Uropathogenic Escherichia coli. Infect. Immun.
73: 7588-7596
[Abstract]
[Full Text]
-
Snyder, J. A., Haugen, B. J., Buckles, E. L., Lockatell, C. V., Johnson, D. E., Donnenberg, M. S., Welch, R. A., Mobley, H. L. T.
(2004). Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection. Infect. Immun.
72: 6373-6381
[Abstract]
[Full Text]
-
Buckles, E. L., Bahrani-Mougeot, F. K., Molina, A., Lockatell, C. V., Johnson, D. E., Drachenberg, C. B., Burland, V., Blattner, F. R., Donnenberg, M. S.
(2004). Identification and Characterization of a Novel Uropathogenic Escherichia coli-Associated Fimbrial Gene Cluster. Infect. Immun.
72: 3890-3901
[Abstract]
[Full Text]
-
Asahara, T., Nomoto, K., Watanuki, M., Yokokura, T.
(2001). Antimicrobial Activity of Intraurethrally Administered Probiotic Lactobacillus casei in a Murine Model of Escherichia coli Urinary Tract Infection. Antimicrob. Agents Chemother.
45: 1751-1760
[Abstract]
[Full Text]
-
Rippere-Lampe, K. E., O'Brien, A. D., Conran, R., Lockman, H. A.
(2001). Mutation of the Gene Encoding Cytotoxic Necrotizing Factor Type 1 (cnf1) Attenuates the Virulence of Uropathogenic Escherichia coli. Infect. Immun.
69: 3954-3964
[Abstract]
[Full Text]
-
Gunther, N. W. IV, Lockatell, V., Johnson, D. E., Mobley, H. L. T.
(2001). In Vivo Dynamics of Type 1 Fimbria Regulation in Uropathogenic Escherichia coli during Experimental Urinary Tract Infection. Infect. Immun.
69: 2838-2846
[Abstract]
[Full Text]
-
Saban, R., Saban, M. R., Nguyen, N.-B., Lu, B., Gerard, C., Gerard, N. P., Hammond, T. G.
(2000). Neurokinin-1 (NK-1) Receptor Is Required in Antigen-Induced Cystitis. Am. J. Pathol.
156: 775-780
[Abstract]
[Full Text]
-
Johnson, D. E., Bahrani, F. K., Lockatell, C. V., Drachenberg, C. B., Hebel, J. R., Belas, R., Warren, J. W., Mobley, H. L. T.
(1999). Serum Immunoglobulin Response and Protection from Homologous Challenge by Proteus mirabilis in a Mouse Model of Ascending Urinary Tract Infection. Infect. Immun.
67: 6683-6687
[Abstract]
[Full Text]
-
Island, M. D., Cui, X., Foxman, B., Marrs, C. F., Stamm, W. E., Stapleton, A. E., Warren, J. W.
(1998). Cytotoxicity of Hemolytic, Cytotoxic Necrotizing Factor 1-Positive and -Negative Escherichia coli to Human T24 Bladder Cells. Infect. Immun.
66: 3384-3389
[Abstract]
[Full Text]